ANGIOTENSIN-I AND ANGIOTENSIN-II EXERT INOTROPIC EFFECTS IN ATRIAL BUT NOT IN VENTRICULAR HUMAN MYOCARDIUM - AN IN-VITRO STUDY UNDER PHYSIOLOGICAL EXPERIMENTAL CONDITIONS

被引:90
作者
HOLUBARSCH, C [1 ]
HASENFUSS, G [1 ]
SCHMIDTSCHWEDA, S [1 ]
KNORR, A [1 ]
PIESKE, B [1 ]
RUF, T [1 ]
FASOL, R [1 ]
JUST, H [1 ]
机构
[1] UNIV FREIBURG, DEPT CARDIOVASC SURG, W-7800 FREIBURG, GERMANY
关键词
ANGIOTENSIN; MYOCARDIUM; INOTROPISM; ANGIOTENSIN CONVERTING ENZYME;
D O I
10.1161/01.CIR.88.3.1228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. The renin-angiotensin system with its renal-humoral and local myocardial components plays an important role in the development and progression of chronic heart failure. Whereas angiotensin receptors have been found in atrial and ventricular myocardium of different species including humans, its influence on myocardial contractility is not yet defined in human failing myocardium and especially in human nonfailing myocardium. Methods and Results. We measured force development of right atrial and right and left ventricular myocardial preparations of patients with a variety of cardiac diseases. To evaluate the physiological effects of angiotensin, experimental temperature and stimulation rates were 37-degrees-C and 60 beats per minute, respectively. Angiotensin I and II increased peak developed force in atrial myocardial preparations obtained from patients without heart failure in a concentration-dependent manner. At optimal concentrations, peak developed force is increased from 10.2+/-1.8 to 12.3+/-1.9 mN/mm2 by angiotensin I (P<.05) and from 15.4+/-2.1 to 20.5+/-3.3 mN/mm2 by angiotensin II (P<.05). This effect was not influenced by pretreatment with propranolol (10(-6) mol/L) and prazosin (10(-5) mol/L) but was completely blocked by saralasin (10(-6) mol/L). The positive inotropic effect of angiotensin I could be blocked by enalaprilate (10(-5) mol/L). Neither angiotensin I nor angiotensin II had any effect in preparations of the left ventricle from patients with idiopathic dilated cardiomyopathy, mitral valve stenosis, and incompetence or in patients with no significant heart disease. Additionally, no effect could be seen when angiotensin II was applied to right ventricular preparations from infants undergoing reconstructive heart surgery for tetralogy of Fallot. Conclusions. Angiotensin I and II exert positive inotropic effects via angiotensin receptors in atrial preparations but not in right or left ventricular preparations. Furthermore, the existence of a local myocardial angiotensin converting enzyme with functional importance is shown.
引用
收藏
页码:1228 / 1237
页数:10
相关论文
共 46 条
[1]   ANGIOTENSIN-II INCREASES SPONTANEOUS CONTRACTILE FREQUENCY AND STIMULATES CALCIUM CURRENT IN CULTURED NEONATAL RAT-HEART MYOCYTES - INSIGHTS INTO THE UNDERLYING BIOCHEMICAL-MECHANISMS [J].
ALLEN, IS ;
COHEN, NM ;
DHALLAN, RS ;
GAA, ST ;
LEDERER, WJ ;
ROGERS, TB .
CIRCULATION RESEARCH, 1988, 62 (03) :524-534
[2]  
[Anonymous], 1871, BERICHTE KONIG SACHS, V23, P652
[3]   IDENTIFICATION AND CHARACTERIZATION OF GUINEA-PIG ANGIOTENSIN-II VENTRICULAR AND ATRIAL RECEPTORS - COUPLING TO INOSITOL PHOSPHATE PRODUCTION [J].
BAKER, KM ;
SINGER, HA .
CIRCULATION RESEARCH, 1988, 62 (05) :896-904
[4]   CHARACTERIZATION OF AVIAN ANGIOTENSIN-II CARDIAC RECEPTORS - COUPLING TO MECHANICAL-ACTIVITY AND PHOSPHOINOSITIDE METABOLISM [J].
BAKER, KM ;
ACETO, JA .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1989, 21 (04) :375-382
[5]  
BAKER KM, 1986, J PHARMACOL EXP THER, V239, P790
[6]   IDENTIFICATION AND CHARACTERIZATION OF THE RABBIT ANGIOTENSIN-II MYOCARDIAL RECEPTOR [J].
BAKER, KM ;
CAMPANILE, CP ;
TRACHTE, GJ ;
PEACH, MJ .
CIRCULATION RESEARCH, 1984, 54 (03) :286-293
[7]   DIFFERENTIATION OF NEUROGENIC AND MYOCARDIAL ANGIOTENSIN-11 RECEPTORS IN ISOLATED RABBIT ATRIA [J].
BLUMBERG, AL ;
ACKERLY, JA ;
PEACH, MJ .
CIRCULATION RESEARCH, 1975, 36 (06) :719-726
[8]  
BONNARDEAUX JL, 1977, ARCH INT PHARMACOD T, V229, P83
[9]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[10]  
BRODDE OE, 1991, PHARMACOL REV, V43, P203